Shopping Cart
Remove All
Your shopping cart is currently empty
NT-0527 is a selective, orally active, and brain-permeable NLRP3 inflammasome inhibitor that inhibits NLRP3-induced IL-1β in human whole blood (IC50 = 0.79 ± 0.4 µM), and can be used for the study of neuroinflammatory diseases.


| Description | NT-0527 is a selective, orally active, and brain-permeable NLRP3 inflammasome inhibitor that inhibits NLRP3-induced IL-1β in human whole blood (IC50 = 0.79 ± 0.4 µM), and can be used for the study of neuroinflammatory diseases. |
| Targets&IC50 | IL-1β:0.79±0.4 μM |
| In vitro | In human whole blood stimulated with LPS and ATP, NT-0527 inhibited NLRP3-induced IL-1β with an IC50 of 0.79 ± 0.4 μM, while having no effect on IL-6 and TNF-α release at concentrations up to 40 μM. [1] |
| Synonyms | NT0527, NT 0527 |
| Molecular Weight | 360.77 |
| Formula | C17H14ClFN4O2 |
| Cas No. | 2771019-10-2 |
| Smiles | O=C1C2=CC=C(Cl)C=C2C3(CN1CC(=O)NC4=NC=C(F)C=N4)CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.